Milton C. Ault III - 16 Dec 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
16 Dec 2022
Net transactions value
+$36,773
Form type
4
Filing time
20 Dec 2022, 15:30:27 UTC
Previous filing
13 Dec 2022
Next filing
20 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $17,960 +20,000 +6.2% $0.8980 345,000 16 Dec 2022 By Ault Alpha LP F1
transaction ALZN Common Stock Purchase $16,358 +20,000 +5.8% $0.8179 365,000 19 Dec 2022 By Ault Alpha LP F1
transaction ALZN Common Stock Purchase $2,455 +3,000 +0.03% $0.8184 11,041,001 19 Dec 2022 By Ault Lending, LLC F2, F3
holding ALZN Common Stock 2,500,000 16 Dec 2022 Direct
holding ALZN Common Stock 14,942,984 16 Dec 2022 By Ault Life Sciences, Inc. F4
holding ALZN Common Stock 10,000,000 16 Dec 2022 By Ault Life Sciences Fund, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F2 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.8184. The range of purchase prices on the transaction date was $0.8154 to $0.8198 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F3 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F5 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.